| Bioactivity | InhA-IN-2 (Compound 23) is a Mycobacterium tuberculosis InhA (an enoyl ACP-reductase) inhibitor with an IC50 of 0.31 μM[1]. |
| Target | IC50: 0.31 μM (InhA) |
| Invitro | InhA-IN-2 (Compound 23) (200 µM, 48h) inhibits mycolic acid synthesis (33% growth inhibition) in M. tuberculosis H37Ra[1]. |
| Name | InhA-IN-2 |
| CAS | 2428737-43-1 |
| Formula | C16H15ClN2O2S2 |
| Molar Mass | 366.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sabbah M, et al. Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors. J Med Chem. 2020 May 14;63(9):4749-4761. |
InhA-IN-2
CAS: 2428737-43-1 F: C16H15ClN2O2S2 W: 366.89
InhA-IN-2 (Compound 23) is a Mycobacterium tuberculosis InhA (an enoyl ACP-reductase) inhibitor with an IC50 of 0.31 μM
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.